Document is current

Article History

Received: 8 October 2024

Accepted: 7 December 2024

First Online: 30 December 2024

Declarations

:

: Jesus Garcia-Donas, corresponding author, has received research funding from Gilead Inc, Pfizer Inc, Merck Inc, Bristol-Myers Squibb, AstraZeneca, Novartis, MSD Inc, Roche Inc, Astellas Inc, Novartis Inc, and Exelixis Inc. He has acted as a speaker for Gilead Inc, Pfizer Inc, Merck Inc, Bristol-Myers Squibb, AstraZeneca, Novartis, Glaxo Smithkline Inc, and MSD Inc. He has served as a scientific advisor for Pfizer Inc, Merck Inc, Bristol-Myers Squibb, AstraZeneca, Novartis, and MSD Inc. Enrique Grande has received honoraria for speaker engagements, advisory roles or funding of continuous medical education from Adacap, AMGEN, Angelini, Astellas, Astra Zeneca, Bayer, Blueprint, Bristol Myers Squibb, Caris Life Sciences, Celgene, Clovis-Oncology, Eisai, Eusa Pharma, Genetracer, Guardant Health, HRA-Pharma, IPSEN, ITM-Radiopharma, Janssen, Lexicon, Lilly, Merck KGaA, MSD, Nanostring Technologies, Natera, Novartis, ONCODNA (Biosequence), Palex, Pharmamar, Pierre Fabre, Pfizer, Roche, Sanofi-Genzyme, Servier, Taiho, and Thermo Fisher Scientific. EG has received research grants from Pfizer, Astra Zeneca, Astellas, and Lexicon Pharmaceuticals. AR has received honoraria for speaker engagements, advisory roles or funding of continuous medical education from Astellas, Bristol Myers Squibb, IPSEN, Pfizer, and MSD.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: All participants provided informed consent prior to their participation.